SG11201705495XA - Identification of functional cell states - Google Patents
Identification of functional cell statesInfo
- Publication number
- SG11201705495XA SG11201705495XA SG11201705495XA SG11201705495XA SG11201705495XA SG 11201705495X A SG11201705495X A SG 11201705495XA SG 11201705495X A SG11201705495X A SG 11201705495XA SG 11201705495X A SG11201705495X A SG 11201705495XA SG 11201705495X A SG11201705495X A SG 11201705495XA
- Authority
- SG
- Singapore
- Prior art keywords
- identification
- functional cell
- cell states
- states
- functional
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B99/00—Subject matter not provided for in other groups of this subclass
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5026—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/40—Searching chemical structures or physicochemical data
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C99/00—Subject matter not provided for in other groups of this subclass
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Computing Systems (AREA)
- Physiology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461927247P | 2014-01-14 | 2014-01-14 | |
| PCT/US2015/011441 WO2015109003A1 (en) | 2014-01-14 | 2015-01-14 | Identification of functional cell states |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201705495XA true SG11201705495XA (en) | 2017-08-30 |
Family
ID=52440877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201705495XA SG11201705495XA (en) | 2014-01-14 | 2015-01-14 | Identification of functional cell states |
Country Status (11)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3094974B1 (en) * | 2014-01-14 | 2019-02-27 | Asedasciences AG | Identification of functional cell states |
| CA2977481C (en) | 2015-02-24 | 2021-02-02 | The University Of Tokyo | Dynamic high-speed high-sensitivity imaging device and imaging method |
| EP4589550A2 (en) * | 2015-10-28 | 2025-07-23 | The University of Tokyo | Analysis device |
| US10824693B2 (en) * | 2015-12-10 | 2020-11-03 | Reservoir Labs, Inc. | Systems and methods for selective expansive recursive tensor analysis |
| US11205103B2 (en) | 2016-12-09 | 2021-12-21 | The Research Foundation for the State University | Semisupervised autoencoder for sentiment analysis |
| US12300357B2 (en) | 2016-12-14 | 2025-05-13 | FlowJo, LLC | Applied computer technology for management, synthesis, visualization, and exploration of parameters in large multi-parameter data sets |
| CN110462372B (zh) * | 2017-05-25 | 2022-06-14 | 佛罗乔有限责任公司 | 大型多参数数据集的可视化、比较分析和自动差异检测 |
| GB2592113B (en) | 2018-06-13 | 2023-01-11 | Thinkcyte Inc | Methods and systems for cytometry |
| CN113826169A (zh) | 2019-05-14 | 2021-12-21 | 匹兹堡大学高等教育联邦体系 | 用于根据多参数细胞和亚细胞成像数据表征细胞表型多样性的系统和方法 |
| CN114930150A (zh) | 2019-12-27 | 2022-08-19 | 新克赛特株式会社 | 评估流式细胞仪性能的方法和标准粒子悬浮液 |
| WO2021200960A1 (ja) | 2020-04-01 | 2021-10-07 | シンクサイト株式会社 | 観察装置 |
| EP4130714A4 (en) | 2020-04-01 | 2024-04-17 | ThinkCyte, Inc. | FLOW CYTOMETER |
| WO2022026532A1 (en) * | 2020-07-30 | 2022-02-03 | Allen Institute | Systems, devices, and methods for compound screening using predictive tagging |
| US20240337647A1 (en) | 2021-07-26 | 2024-10-10 | Asedasciences Ag | Improved methods for identification of functional cell states |
| WO2023056481A1 (en) * | 2021-10-01 | 2023-04-06 | CAP Diagnostics, LLC, dba Pathnostics | Automated methods and systems for rapid identification of target particles |
| US12105081B2 (en) * | 2021-10-20 | 2024-10-01 | Travera, Inc. | Treatment response assessment using normalized single cell measurements |
| IL322273A (en) | 2023-01-23 | 2025-09-01 | Asedasciences Ag | Improved human-computer interaction systems |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5544650A (en) | 1988-04-08 | 1996-08-13 | Neuromedical Systems, Inc. | Automated specimen classification system and method |
| AU6024294A (en) | 1993-01-08 | 1994-08-15 | Coulter Corporation | Method of using preserved control cells in the calibration of fluorescent and light scatter measurements |
| CA2196496A1 (en) | 1997-01-31 | 1998-07-31 | Stephen William Watson Michnick | Protein fragment complementation assay for the detection of protein-protein interactions |
| US7166424B2 (en) | 1998-02-02 | 2007-01-23 | Odyssey Thera Inc. | Fragments of fluorescent proteins for protein fragment complementation assays |
| US20050221280A1 (en) * | 1998-02-02 | 2005-10-06 | Odyssey Thera, Inc. | Protein-protein interactions for pharmacological profiling |
| US6801859B1 (en) | 1998-12-23 | 2004-10-05 | Rosetta Inpharmatics Llc | Methods of characterizing drug activities using consensus profiles |
| US6998249B1 (en) * | 1999-09-27 | 2006-02-14 | Pharmacia & Upjohn Company | Toxicity screening method |
| AU2001240074B2 (en) | 2000-03-06 | 2006-02-23 | Bioseek, Inc. | Function homology screening |
| EP1290428A1 (en) * | 2000-06-02 | 2003-03-12 | Medicometrics APS | Method and system for classifying a biological sample |
| US7146349B2 (en) | 2000-11-06 | 2006-12-05 | International Business Machines Corporation | Network for describing multimedia information |
| WO2004094992A2 (en) * | 2003-04-23 | 2004-11-04 | Bioseek, Inc. | Methods for analysis of biological dataset profiles |
| WO2004094609A2 (en) | 2003-04-23 | 2004-11-04 | Bioseek, Inc. | Methods for characterizing signaling pathways and compounds that interact therewith |
| WO2008134593A1 (en) | 2007-04-25 | 2008-11-06 | President And Fellows Of Harvard College | Molecular circuits |
| US20130226469A1 (en) | 2008-04-01 | 2013-08-29 | Purdue Research Foundation | Gate-free flow cytometry data analysis |
| US8831889B2 (en) | 2008-04-01 | 2014-09-09 | Purdue Research Foundation | Quantification of differences between measured values and statistical validation based on the differences |
| EP3094974B1 (en) * | 2014-01-14 | 2019-02-27 | Asedasciences AG | Identification of functional cell states |
-
2015
- 2015-01-14 EP EP15702063.7A patent/EP3094974B1/en active Active
- 2015-01-14 AU AU2015206520A patent/AU2015206520B2/en active Active
- 2015-01-14 DK DK15702063.7T patent/DK3094974T3/da active
- 2015-01-14 JP JP2016563912A patent/JP6606100B2/ja active Active
- 2015-01-14 US US14/596,957 patent/US20150198584A1/en not_active Abandoned
- 2015-01-14 WO PCT/US2015/011441 patent/WO2015109003A1/en active Application Filing
- 2015-01-14 KR KR1020167022058A patent/KR102413041B1/ko active Active
- 2015-01-14 SG SG11201705495XA patent/SG11201705495XA/en unknown
- 2015-01-14 CA CA2972960A patent/CA2972960C/en active Active
- 2015-01-14 US US15/111,339 patent/US11137388B2/en active Active
- 2015-01-14 ES ES15702063T patent/ES2728119T3/es active Active
-
2016
- 2016-07-12 IL IL246734A patent/IL246734B/en active IP Right Grant
-
2021
- 2021-06-28 AU AU2021204419A patent/AU2021204419A1/en not_active Abandoned
- 2021-08-05 US US17/394,521 patent/US11867690B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11137388B2 (en) | 2021-10-05 |
| JP6606100B2 (ja) | 2019-11-13 |
| KR20160110444A (ko) | 2016-09-21 |
| US20150198584A1 (en) | 2015-07-16 |
| DK3094974T3 (da) | 2019-05-27 |
| WO2015109003A1 (en) | 2015-07-23 |
| JP2017505140A (ja) | 2017-02-16 |
| ES2728119T3 (es) | 2019-10-22 |
| CA2972960C (en) | 2022-01-11 |
| AU2015206520A1 (en) | 2016-07-14 |
| US20210364499A1 (en) | 2021-11-25 |
| US20160370350A1 (en) | 2016-12-22 |
| EP3094974A1 (en) | 2016-11-23 |
| AU2015206520B2 (en) | 2021-07-22 |
| IL246734A0 (en) | 2016-08-31 |
| IL246734B (en) | 2019-06-30 |
| AU2021204419A1 (en) | 2021-07-22 |
| HK1231553A1 (en) | 2017-12-22 |
| CA2972960A1 (en) | 2015-07-23 |
| US11867690B2 (en) | 2024-01-09 |
| KR102413041B1 (ko) | 2022-06-23 |
| EP3094974B1 (en) | 2019-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274903A (en) | cell | |
| IL246734B (en) | Identification of functional cell states | |
| IL250511A0 (en) | Crystalline forms of ibrutinib | |
| SG11201609265RA (en) | Characterizing states of subject | |
| GB201419865D0 (en) | Solution | |
| IL239830B (en) | Case | |
| GB201407805D0 (en) | Battery condition determination | |
| AU359704S (en) | Case | |
| PL3509156T3 (pl) | Roztwór elektrolitu | |
| SG11201610831PA (en) | Lithium-sulphur battery | |
| SG11201610430QA (en) | Growth-independent detection of cells | |
| GB2531512B (en) | Context-sensitive identification of regions of interest | |
| GB201411985D0 (en) | Battery | |
| HUE042287T2 (hu) | Lítium-kén cella | |
| GB2531332B (en) | Location identification | |
| GB2559497B (en) | Functional wall-tie | |
| GB201604427D0 (en) | Modified cell | |
| GB201414968D0 (en) | Cell assay | |
| GB201413459D0 (en) | Identification of objects | |
| GB201403494D0 (en) | Identifying cell features | |
| GB201413650D0 (en) | Wallets | |
| GB201410934D0 (en) | T cell | |
| GB201419149D0 (en) | Wallet | |
| GB201417979D0 (en) | Abstract accelerationon | |
| GB201419897D0 (en) | Host cell |